Chief Medical Officer

Chief Technical Officer

Immuno-Oncology Drugs Market Projected to Reach US$ 185.69 Billion by 2035 | Astute Analytica

Oncolytic Virus Therapy Market Set to Reach USD 199.98 Million by 2033, Led by North America's 33.50% Market Share

In Depth: Where China Stands in the Nuclear Medicine Gold Rush

Protein Therapeutics Market to Worth Over US$ 426.8 Billion by 2033 | Astute Analytica

Director, CMC Project Leadership

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines. The Director, CMC Project Leadership will lead CMC efforts for the lead asset, FPI-2265, and represent CMC on the Global Program team, ensuring effective development and commercialization of new medicines.

Director, Cmc Project Leadership in united states (1000+)

Director, CMC Project Leadership